A Comprehensive and Comparative study of qualification process for Drug Development tools in US, Europe, Japan and India
Journal Title: International Journal of Drug Regulatory Affairs - Year 2018, Vol 6, Issue 2
Abstract
Drug Development Tools are methods, materials, or measures that have the potential to facilitate drug development. USFDA has specified three major drug development tools and has also given the guidelines recommending their qualification which would expedite the drug development process. This qualification would ensure better understanding of drug targets and long term safety outcomes. Regulatory authorities of Europe, Japan & India have also focused on developing a formal qualification process of drug development tools though most of it follows USFDA.
Authors and Affiliations
Garima Kshatriya, Dilip G. Maheshwari
Keywords
Related Articles
- EP ID EP329285
- DOI 10.22270/ijdra.v6i2.227
- Views 112
- Downloads 0
Regulation of Blood and Blood products in India, USA and EU
Blood and blood products are precious commodity which gives life to another person. Though we have immense discoveries and invention in science and technology, yet we cannot make blood hence, human blood has no substitut...
FORMULATION AND EVALUATION OF SOLID DISPERSION OF TADALAFIL
Tadalafil is used for the treatment of the erectile dysfunction (ED) and pulmonary arterial hypertension. It is having low aqueous solubility thus it shows poor bioavailability of about 28% by after oral administration....
WEARABLE HEALTHCARE TECHNOLOGY – THE REGULATORY PERSPECTIVE
The world today isn’t the one which it was yesterday. With the continuing evolution in technology and technological applications on medical field, innovative products and services have been emerging every day. Wearable g...
RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF TELMISARTAN IN BULK AND TABLET DOSAGE FORM
A simple, sensitive, precise and specific reverse phase high performance liquid chromatographic method was developed and validated for the determination of Telmisartan in bulk and tablet dosage forms. It was found that t...
Regulatory requirements for the approval of Anti-Cancer drug (Mercaptopurine) in Myanmar as per ACTD
South East Asian pharmaceutical market is growing rapidly. In Asian country, the regulatory environment is similar among all countries. But still requirements and process of registration is varying among countries of Asi...